NCT06240741 2026-02-03
A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan
Novartis
Phase 3 Completed
Novartis
Hong Kong Sanatorium & Hospital
Ohio State University Comprehensive Cancer Center